id CRUZ_d266a9483d77645702179d50bcc667f4
oai_identifier_str oai:www.arca.fiocruz.br:icict/43042
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Jeronimo, Christiane Maria PradoFarias, Maria Eduarda LeãoVal, Fernando Fonseca AlmeidaSampaio, Vanderson SouzaAlexandre, Marcia Almeida AraújoMelo, Gisely CardosoSafe, Izabella PicininBorba, Mayla Gabriela SilvaAbreu-Netto, Rebeca LinharesMaciel, Alex Bezerra SilvaNeto, João Ricardo SilvaOliveira, Lucas BarbosaFigueiredo, Erick Frota GomesDinelly, Kelry Mazurega OliveiraRodrigues, Maria Gabriela de AlmeidaBrito, MarceloMourão, Maria Paula GomesPivoto-João, Guilherme AugustoHajjar, Ludhmila AbrahãoBassat, QuiqueRomero, Gustavo Adolfo SierraNaveca, Felipe GomesVasconcelos, Heline LiraTavares, Michel de AraújoBrito-Sousa, José DiegoCosta, Fabio Trindade MaranhãoNogueira, Maurício LacerdaBaía-da-Silva, DjaneXavier, Mariana SimãoMonteiro, Wuelton MarceloLacerda, Marcus Vinícius Guimarãesthe Metcovid Team2020-08-27T20:43:45Z2020-08-27T20:43:45Z2020JERONIMO, Christiane Maria Prado et al. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial. Clinical Infectious Diseases, p. 1-35, 2020.1058-4838https://www.arca.fiocruz.br/handle/icict/4304210.1093/cid/ciaa11771537-6591engMethylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trialinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas & Maria Deane. Manaus, AM, Brasil / Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil / Fundação de Vigilância em Saúde do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Universidade de São Paulo. Faculdade de Medicina. São Paulo, SP, Brasil.Hospital Clínic-Universitat de Barcelona. ISGlobal. Barcelona, Spain / Centro de Investigação em Saúde de Manhiça. Maputo, Mozambique / ICREA. Barcelona, Spain / University of Barcelona. Hospital Sant Joan de Dé. Pediatrics Department. Pediatric Infectious Diseases Unit. Barcelona, Spain / Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública. Madrid, Spain.Universidade de Brasília. Núcleo de Medicina Tropical. Brasília, DF, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas & Maria Deane. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil.Universidade Federal do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Universidade Estadual de Campinas. Campinas, SP, Brasil.Faculdade de Medicina de São José do Rio Preto. São José do Rio Preto, SP, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas & Maria Deane. Manaus, AM, Brasil / Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.Background: Steroid use for COVID-19 is based on the possible role of these drugs in mitigating the inflammatory response, mainly in the lungs, triggered by SARS-CoV-2. This study aimed at evaluating at evaluating the efficacy of methylprednisolone (MP) among hospitalized patients with suspected COVID-19. Methods: Parallel, double-blind, placebo-controlled, randomized, phase IIb clinical trial was performed with hospitalized patients aged ≥ 18 years with clinical, epidemiological and/or radiological suspected COVID-19, at a tertiary care facility in Manaus, Brazil. Patients were randomly allocated (1:1 ratio) to receive either intravenous MP (0.5 mg/kg) or placebo (saline solution), twice daily, for 5 days. A modified intention-to-treat (mITT) analysis was conducted. The primary outcome was 28-day mortality. ClinicalTrials Identifier NCT04343729. Findings: From April 18 to June 16, 2020, 647 patients were screened, 416 randomized, and 393 analyzed as mITT, MP in 194 and placebo in 199 individuals. SARS-CoV-2 infection was confirmed by RT-PCR in 81.3%. Mortality at day 28 was not different between groups. A subgroup analysis showed that patients over 60 years in the MP group had a lower mortality rate at day 28. Patients in the MP arm tended to need more insulin therapy, and no difference was seen in virus clearance in respiratory secretion until day 7. Conclusion: The findings of this study suggest that a short course of MP in hospitalized patients with COVID-19 did not reduce mortality in the overall population.COVID-19CoronavirusSARS-CoV-2CorticosteroidInflammationBrazilinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83097https://www.arca.fiocruz.br/bitstream/icict/43042/1/license.txt73c2438d9038594f05d706f987b602c3MD51ORIGINALJeronimo_Christiane_etal_INI_2020_COVID-19.pdfJeronimo_Christiane_etal_INI_2020_COVID-19.pdfapplication/pdf1317198https://www.arca.fiocruz.br/bitstream/icict/43042/2/Jeronimo_Christiane_etal_INI_2020_COVID-19.pdf71ce54bcaa0e77f8f95ebbac4988345fMD52TEXTJeronimo_Christiane_etal_INI_2020_COVID-19.pdf.txtJeronimo_Christiane_etal_INI_2020_COVID-19.pdf.txtExtracted texttext/plain54290https://www.arca.fiocruz.br/bitstream/icict/43042/3/Jeronimo_Christiane_etal_INI_2020_COVID-19.pdf.txt4fc4dd2b5acebc619b60a306f47f4d80MD53icict/430422020-08-31 10:58:52.301oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352020-08-31T13:58:52Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
title Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
spellingShingle Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
Jeronimo, Christiane Maria Prado
COVID-19
Coronavirus
SARS-CoV-2
Corticosteroid
Inflammation
Brazil
title_short Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
title_full Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
title_fullStr Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
title_full_unstemmed Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
title_sort Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
author Jeronimo, Christiane Maria Prado
author_facet Jeronimo, Christiane Maria Prado
Farias, Maria Eduarda Leão
Val, Fernando Fonseca Almeida
Sampaio, Vanderson Souza
Alexandre, Marcia Almeida Araújo
Melo, Gisely Cardoso
Safe, Izabella Picinin
Borba, Mayla Gabriela Silva
Abreu-Netto, Rebeca Linhares
Maciel, Alex Bezerra Silva
Neto, João Ricardo Silva
Oliveira, Lucas Barbosa
Figueiredo, Erick Frota Gomes
Dinelly, Kelry Mazurega Oliveira
Rodrigues, Maria Gabriela de Almeida
Brito, Marcelo
Mourão, Maria Paula Gomes
Pivoto-João, Guilherme Augusto
Hajjar, Ludhmila Abrahão
Bassat, Quique
Romero, Gustavo Adolfo Sierra
Naveca, Felipe Gomes
Vasconcelos, Heline Lira
Tavares, Michel de Araújo
Brito-Sousa, José Diego
Costa, Fabio Trindade Maranhão
Nogueira, Maurício Lacerda
Baía-da-Silva, Djane
Xavier, Mariana Simão
Monteiro, Wuelton Marcelo
Lacerda, Marcus Vinícius Guimarães
the Metcovid Team
author_role author
author2 Farias, Maria Eduarda Leão
Val, Fernando Fonseca Almeida
Sampaio, Vanderson Souza
Alexandre, Marcia Almeida Araújo
Melo, Gisely Cardoso
Safe, Izabella Picinin
Borba, Mayla Gabriela Silva
Abreu-Netto, Rebeca Linhares
Maciel, Alex Bezerra Silva
Neto, João Ricardo Silva
Oliveira, Lucas Barbosa
Figueiredo, Erick Frota Gomes
Dinelly, Kelry Mazurega Oliveira
Rodrigues, Maria Gabriela de Almeida
Brito, Marcelo
Mourão, Maria Paula Gomes
Pivoto-João, Guilherme Augusto
Hajjar, Ludhmila Abrahão
Bassat, Quique
Romero, Gustavo Adolfo Sierra
Naveca, Felipe Gomes
Vasconcelos, Heline Lira
Tavares, Michel de Araújo
Brito-Sousa, José Diego
Costa, Fabio Trindade Maranhão
Nogueira, Maurício Lacerda
Baía-da-Silva, Djane
Xavier, Mariana Simão
Monteiro, Wuelton Marcelo
Lacerda, Marcus Vinícius Guimarães
the Metcovid Team
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Jeronimo, Christiane Maria Prado
Farias, Maria Eduarda Leão
Val, Fernando Fonseca Almeida
Sampaio, Vanderson Souza
Alexandre, Marcia Almeida Araújo
Melo, Gisely Cardoso
Safe, Izabella Picinin
Borba, Mayla Gabriela Silva
Abreu-Netto, Rebeca Linhares
Maciel, Alex Bezerra Silva
Neto, João Ricardo Silva
Oliveira, Lucas Barbosa
Figueiredo, Erick Frota Gomes
Dinelly, Kelry Mazurega Oliveira
Rodrigues, Maria Gabriela de Almeida
Brito, Marcelo
Mourão, Maria Paula Gomes
Pivoto-João, Guilherme Augusto
Hajjar, Ludhmila Abrahão
Bassat, Quique
Romero, Gustavo Adolfo Sierra
Naveca, Felipe Gomes
Vasconcelos, Heline Lira
Tavares, Michel de Araújo
Brito-Sousa, José Diego
Costa, Fabio Trindade Maranhão
Nogueira, Maurício Lacerda
Baía-da-Silva, Djane
Xavier, Mariana Simão
Monteiro, Wuelton Marcelo
Lacerda, Marcus Vinícius Guimarães
the Metcovid Team
dc.subject.en.pt_BR.fl_str_mv COVID-19
Coronavirus
SARS-CoV-2
Corticosteroid
Inflammation
Brazil
topic COVID-19
Coronavirus
SARS-CoV-2
Corticosteroid
Inflammation
Brazil
description Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Manaus, AM, Brasil.
publishDate 2020
dc.date.accessioned.fl_str_mv 2020-08-27T20:43:45Z
dc.date.available.fl_str_mv 2020-08-27T20:43:45Z
dc.date.issued.fl_str_mv 2020
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv JERONIMO, Christiane Maria Prado et al. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial. Clinical Infectious Diseases, p. 1-35, 2020.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/43042
dc.identifier.issn.pt_BR.fl_str_mv 1058-4838
dc.identifier.doi.pt_BR.fl_str_mv 10.1093/cid/ciaa1177
dc.identifier.eissn.pt_BR.fl_str_mv 1537-6591
identifier_str_mv JERONIMO, Christiane Maria Prado et al. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial. Clinical Infectious Diseases, p. 1-35, 2020.
1058-4838
10.1093/cid/ciaa1177
1537-6591
url https://www.arca.fiocruz.br/handle/icict/43042
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/43042/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/43042/2/Jeronimo_Christiane_etal_INI_2020_COVID-19.pdf
https://www.arca.fiocruz.br/bitstream/icict/43042/3/Jeronimo_Christiane_etal_INI_2020_COVID-19.pdf.txt
bitstream.checksum.fl_str_mv 73c2438d9038594f05d706f987b602c3
71ce54bcaa0e77f8f95ebbac4988345f
4fc4dd2b5acebc619b60a306f47f4d80
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009002856972288